Published in J Clin Invest on May 01, 1991
Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy. Am J Pathol (2007) 0.87
Treatment of passively transferred experimental autoimmune myasthenia gravis using papain. Clin Exp Immunol (2000) 0.79
Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy. Sci Rep (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem (1979) 9.06
In vitro processing of pro-subtilisin produced in Escherichia coli. J Biol Chem (1988) 1.55
The effect of antigen excess on chronic immune complex glomerulonephritis. Johns Hopkins Med J (1969) 1.23
A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome. N Engl J Med (1979) 1.13
Treatment of idiopathic membranous nephropathy. N Engl J Med (1976) 1.12
Mechanisms and consequences of proteinuria. Lab Invest (1986) 1.05
Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. J Exp Med (1986) 1.02
Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest (1990) 1.00
Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes. Lab Invest (1986) 0.98
Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin. J Clin Invest (1982) 0.94
Cleavage of one specific disulfide bond in papain. J Biol Chem (1969) 0.94
Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease. Lab Invest (1983) 0.93
Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med (1977) 0.89
[In vivo degradation of immune complexes in the kidney by orally administered enzymes]. Wien Klin Wochenschr (1987) 0.89
Immune complex effects on glomerular eicosanoid production and renal hemodynamics. Kidney Int (1987) 0.83
[High-dose gamma globulin therapy for membranous nephropathy, membranoproliferative glomerulonephritis and lupus nephritis]. Nihon Jinzo Gakkai Shi (1983) 0.83
Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy. Lab Invest (1988) 0.82
Interaction of immune complexes with glomerular heparan sulfate-proteoglycans. Kidney Int (1986) 0.81
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Improved complementation in the cytotoxic test. Transplantation (1970) 3.93
Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. J Immunol (1979) 3.37
Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny. J Exp Med (1975) 3.26
The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell (2000) 3.19
Cellular aspects of immunoglobulin A. Adv Immunol (1976) 2.44
Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest (1981) 2.24
Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A (1992) 2.24
The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A (1991) 2.02
Polypeptide chain structure of rabbit immunoglobulins. I. gamma-G-immunoglobulin. Biochemistry (1966) 2.00
Localization of free and bound secretory component in human intestinal epithelial cells. A model for the assembly of secretory IgA. J Exp Med (1974) 1.91
Combined oral/nasal immunization protects mice from Sendai virus infection. J Immunol (1987) 1.90
A three-tiered view of the role of IgA in mucosal defense. Immunol Today (1993) 1.84
Characteristics of mesenteric lymph node cells homing to gut-associated lymphoid tissue in syngeneic mice. J Immunol (1975) 1.84
Polypeptide chain structure of rabbit immunoglobulins. II. gamma-M-immunoglobulin. Biochemistry (1966) 1.84
The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol (1987) 1.80
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology (2001) 1.79
The link between hypertension and nephrosclerosis. Am J Kidney Dis (1995) 1.77
Origin of IgA-secreting plasma cells in the mammary gland. J Exp Med (1977) 1.71
Cell surface immunoglobulin. X. Identification of an IgD-like molecule on the surface of murine splenocytes. J Exp Med (1974) 1.70
Mesenteric lymph node B lymphoblasts which home to the small intestine are precommitted to IgA synthesis. J Exp Med (1977) 1.63
Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody. J Immunol (1968) 1.62
Synthesis of immunoglobulin heavy and light chains by the free ribosomes of a mouse plasma cell tumor. Proc Natl Acad Sci U S A (1970) 1.62
Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J Immunol (1988) 1.60
Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology (1997) 1.51
Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood. J Clin Invest (1976) 1.46
Unstable inter-H chain disulfide bonding and non-covalently associated J chain in rat dimeric IgA. Mol Immunol (1993) 1.45
Experimental IgA nephropathy induced by oral immunization. J Exp Med (1983) 1.45
Immunoglobulin A monoclonal antibodies protect against Sendai virus. J Virol (1987) 1.44
Presence of two types of L polypeptide chains in guinea pig 7S immunoglobulins. J Exp Med (1966) 1.43
IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest (1989) 1.41
Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes. J Exp Med (1982) 1.39
Inhibition of microbial IgA proteases by human secretory IgA and serum. Mol Immunol (1983) 1.38
Extra-adrenal myelolipoma: report of two cases. South Med J (1995) 1.35
Studies on cell-free synthesis of rat immunoglobulins, II. Synthesis of immunoglobulin and of antibody to the dinitrophenyl hapten. Proc Natl Acad Sci U S A (1967) 1.32
Protein disulphide-isomerase from human placenta and rat liver. Purification and immunological characterization with monoclonal antibodies. Biochem J (1987) 1.31
Hormonal induction of the secretory immune system in the mammary gland. Proc Natl Acad Sci U S A (1978) 1.29
Synthesis of secretory component by colonic neoplasms. Am J Pathol (1976) 1.29
Cell-free synthesis of rat immunoglobulin. 3. Analysis of the cell-free made chains and of their mode of assembly. J Mol Biol (1971) 1.26
Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge. Lab Invest (1983) 1.24
Surface and intracellular markers of mouse mesenteric and peripheral lymph node and Peyer's patch cells. J Immunol (1974) 1.23
Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest (1991) 1.22
Isolation of purified H and L polypeptide chains from guinea-pig gamma-2-immunoglobulin after mild reduction. Immunology (1966) 1.22
Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int (1983) 1.20
Regulation of the immune response: suppressive and enhancing effects of passively administered antibody. J Exp Med (1971) 1.20
Human secretory component. Comparison of the form occurring in exocrine immunoglobulin A to the free form. Biochemistry (1972) 1.18
Plasma cells and epithelial immunoglobulins in the mouse mammary gland during pregnancy and lactation. J Immunol (1977) 1.17
Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis. J Pharmacol Exp Ther (1985) 1.12
IgA nephropathy: overproduction or decreased clearance of immune complexes? Lab Invest (1989) 1.11
Secretory immunoglobulins in colonic neoplasms. Am J Pathol (1976) 1.10
Biologic activities of rabbit immunoglobulin G in relation to domains of the Fc region. J Immunol (1976) 1.09
Selective chemotaxis of subsets of B lymphocytes from gut-associated lymphoid tissue and its implications for the recruitment of mucosal plasma cells. J Immunol (1986) 1.08
Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Am J Transplant (2009) 1.06
Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release. Evidence for an Fc receptor. J Immunol (1987) 1.06
IgA nephropathy: perspectives on pathogenesis and classification. Clin Nephrol (1985) 1.05
Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant (2008) 1.05
Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and aging. Diabetes (1988) 1.04
Interstrain variations in nephritogenicity of heterologous protein in mice. Lab Invest (1982) 1.04
Gut-associated lymphoid tissue as source of an IgA immune response in respiratory tissues after oral immunization and intrabronchial challenge. Cell Immunol (1987) 1.03
Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med (1996) 1.03
Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. J Exp Med (1986) 1.02
Nondissociating cationic immune complexes can deposit in glomerular basement membrane. J Exp Med (1983) 1.01
Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest (1990) 1.00
A mucosal IgA-mediated excretory immune system in vivo. J Immunol (2001) 1.00
Cell surface immunoglobulin. XIV. Synthesis, surface expression, and secretion of immunoglobulin by Peyer's patch cells in the mouse. J Immunol (1975) 0.99
The role of mesangial complement in the hematuria of experimental IgA nephropathy. Lab Invest (1987) 0.98
Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes. Lab Invest (1986) 0.98
The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immunol (1997) 0.97
Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. J Immunol (1989) 0.97
Migration and regulation of B-cells in the mucosal immune system. Ann N Y Acad Sci (1983) 0.97
Comparative studies of transcytosis and assembly of secretory IgA in Madin-Darby canine kidney cells expressing human polymeric Ig receptor. J Immunol (1995) 0.97
Monoclonal antibodies to human complement receptor (CR1) detect defects in glomerular diseases. Clin Immunol Immunopathol (1983) 0.97
T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol (2001) 0.96
Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr Res (1994) 0.95
Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res (1992) 0.95
Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am J Pathol (1993) 0.95
J chain is covalently bound to both monomer subunits in human secretory IgA. J Biol Chem (1981) 0.93
Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium. J Exp Med (1998) 0.92
Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant (2011) 0.91
Inhibition of bacterial IgA proteases by human secretory IgA and serum. Ann N Y Acad Sci (1983) 0.91
Effect of a disulfide-interchange enzyme on the assembly of human secretory immunoglobulin A from immunoglobulin A and free secretory component. J Biol Chem (1979) 0.91
Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab Invest (1994) 0.91
Reactive half-cystine peptides of the secretory component of human exocrine immunoglobulin A. J Biol Chem (1975) 0.90
Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis. Am J Pathol (1996) 0.90
Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred. Clin Exp Immunol (1994) 0.89
Histoplasmosis and kidney disease in patients with AIDS. Clin Infect Dis (1997) 0.88
Interaction of antigen load and antibody response in determining heterologous protein nephritogenicity in inbred mice. Lab Invest (1983) 0.88
Cholera toxin as a mucosal adjuvant. Glutaraldehyde treatment dissociates adjuvanticity from toxicity. J Immunol (1989) 0.88
Disulfide bond formation between dimeric immunoglobulin A and the polymeric immunoglobulin receptor during hepatic transcytosis. Hepatology (1994) 0.88
Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Am J Kidney Dis (1994) 0.88
Induction of secretory component synthesis in colonic epithelial cells. Adv Exp Med Biol (1987) 0.88